Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

The moments of excitement over the Dallas Cowboys perhaps getting involved in the playoff race turned out to be nothing but false hope. The Cowboys won three in a row to get back in the playoff ...

The Big Ten Championship Game is between Julian Sayin and the No. 1 Ohio State Buckeyes (12-0) and the No. 2 Indiana Hoosiers (12-0) on December 6, 2025. Kickoff is at 8 p.m. ET on FOX. Keep up with ...

No. 2 Indiana stunned No. 1 Ohio State 13-10 to clinch its first outright Big Ten championship since 1945. The win all but secures the No. 1 overall seed in the College Football Playoff and sends the ...

No. 2 Indiana claimed its biggest win in program history, knocking off No. 1 Ohio State 13-10 to win the Big Ten Championship Game. It is Indiana’s first outright Big Ten title since 1945. The ...